Literature DB >> 5917390

Studies on debrisoquine sulphate.

A H Kitchin, R W Turner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5917390      PMCID: PMC1943918          DOI: 10.1136/bmj.2.5516.728

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  CARDIOVASCULAR EFFECTS OF 3,4-DIHYDRO-2(1H) ISOQUINOLINE CARBOXAMIDINE (DECLINAX-T.M.).

Authors:  R A MOE; H M BATES; Z M PALKOSKI; R BANZIGER
Journal:  Curr Ther Res Clin Exp       Date:  1964-04

2.  GUANETHIDINE IN THE TREATMENT OF HYPERTENSION.

Authors:  C P LOWTHER; R W TURNER
Journal:  Br Med J       Date:  1963-09-28

3.  Treatment of hypertension with methyldopa.

Authors:  P Johnson; A H Kitchin; C P Lowther; R W Turner
Journal:  Br Med J       Date:  1966-01-15
  3 in total
  5 in total

1.  Variation in the modification of cardiovascular responses by sympathetic inhibitory drugs.

Authors:  B N Prichard
Journal:  Proc R Soc Med       Date:  1969-01

2.  Why hypertensive patients vary in their response to oral debrisoquine.

Authors:  J H Silas; M S Lennard; G T Tucker; A J Smith; S L Malcolm; T R Marten
Journal:  Br Med J       Date:  1977-02-12

3.  Drug resistance, inappropriate dosing and non-compliance in hypertensive patients.

Authors:  J H Silas; G T Tucker; A J Smith
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

4.  Clinical experience with bethanidine in treatment of hypertension.

Authors:  J Bath; D Pickering; R Turner
Journal:  Br Med J       Date:  1967-12-02

5.  The metabolism of [14C]-debrisoquine in man.

Authors:  J R Idle; A Mahgoub; M M Angelo; L G Dring; R Lancaster; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.